//php print_r(get_the_ID()); ?>
Recently, CDSCO has approved Boehringer Ingelheim’s anti-diabetic drug for the treatment of Chronic kidney disease in India.
Central Drugs Standard Control Organization (CDSCO)
|
---|
News Source: Live Mint
Must Read | |
NCERT Notes For UPSC | UPSC Daily Current Affairs |
UPSC Blogs | UPSC Daily Editorials |
Daily Current Affairs Quiz | Daily Main Answer Writing |
UPSC Mains Previous Year Papers | UPSC Test Series 2024 |
To get PDF version, Please click on "Print PDF" button.
As Pakistan and Bangladesh Get Close, India Should...
Steering the Decarbonisation of India’s Logistic...
Civil Service for Viksit Bharat in the Vision of S...
Are Indian Startups not Scaling up on Innovation?
Biodiversity Under Threat, What We Need To Do
India’s Success in Space Research Shows Why We N...
<div class="new-fform">
</div>